Industry Research Reports

Home > Reports > Medical Care > Global Diabetes Therapeutics and Diagnostics Market Research Report 2026

Global Diabetes Therapeutics and Diagnostics Market Research Report 2026

Industry: Medical Care

Published Date: 2026-04-28

Pages: 144 Pages

Report ld: 6690382

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetes Therapeutics and Diagnostics Market Size(US$)

CAGR 2026-2032

2.5%

Market Size,2032

USD 153,410

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 132,280 million

Market Forecast in 2032(Value)

US$ 153,410 million

CAGR

2.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Diabetes Therapeutics and Diagnostics market was valued at US$ 129370 million in 2025 and is anticipated to reach US$ 153410 million by 2032, at a CAGR of 2.5% from 2026 to 2032.

This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Diabetes Therapeutics and Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Therapeutics and Diagnostics. The Diabetes Therapeutics and Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Diabetes Therapeutics and Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Diabetes Therapeutics and Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others

Segment by Application

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Diabetes Therapeutics and Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Insulin

1.2.3 Insulin Delivery

1.2.4 Oral Hypoglycemic Drugs

1.2.5 Diagnosis And Monitoring

1.2.6 Others

1.3 Market by Application

1.3.1 Global Diabetes Therapeutics and Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.3.4 Gestational Diabetes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetes Therapeutics and Diagnostics Market Perspective (2021–2032)

2.2 Global Diabetes Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Global Diabetes Therapeutics and Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Diabetes Therapeutics and Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Diabetes Therapeutics and Diagnostics Market Dynamics

2.3.1 Diabetes Therapeutics and Diagnostics Industry Trends

2.3.2 Diabetes Therapeutics and Diagnostics Market Drivers

2.3.3 Diabetes Therapeutics and Diagnostics Market Challenges

2.3.4 Diabetes Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue

3.1.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Diabetes Therapeutics and Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Diabetes Therapeutics and Diagnostics Revenue

3.4 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapeutics and Diagnostics Revenue in 2025

3.5 Global Key Players of Diabetes Therapeutics and Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Diabetes Therapeutics and Diagnostics, Products and Applications

3.7 Global Key Players of Diabetes Therapeutics and Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Diabetes Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2027–2032)

5 Diabetes Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Diabetes Therapeutics and Diagnostics Market Size (2021–2032)

6.2 North America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2021–2026)

6.4 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetes Therapeutics and Diagnostics Market Size (2021–2032)

7.2 Europe Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2021–2026)

7.4 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Diabetes Therapeutics and Diagnostics Market Size (2021–2032)

9.2 Latin America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 77 Elektronika Kft.

11.1.1 77 Elektronika Kft. Company Details

11.1.2 77 Elektronika Kft. Business Overview

11.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Introduction

11.1.4 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.1.5 77 Elektronika Kft. Recent Development

11.2 A. Menarini Diagnostics S.R.L

11.2.1 A. Menarini Diagnostics S.R.L Company Details

11.2.2 A. Menarini Diagnostics S.R.L Business Overview

11.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Introduction

11.2.4 A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.2.5 A. Menarini Diagnostics S.R.L Recent Development

11.3 Abbott Laboratories

11.3.1 Abbott Laboratories Company Details

11.3.2 Abbott Laboratories Business Overview

11.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Introduction

11.3.4 Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.3.5 Abbott Laboratories Recent Development

11.4 Agamatrix Inc.

11.4.1 Agamatrix Inc. Company Details

11.4.2 Agamatrix Inc. Business Overview

11.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Introduction

11.4.4 Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.4.5 Agamatrix Inc. Recent Development

11.5 Animas Corp.

11.5.1 Animas Corp. Company Details

11.5.2 Animas Corp. Business Overview

11.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Introduction

11.5.4 Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.5.5 Animas Corp. Recent Development

11.6 Ascensia

11.6.1 Ascensia Company Details

11.6.2 Ascensia Business Overview

11.6.3 Ascensia Diabetes Therapeutics and Diagnostics Introduction

11.6.4 Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.6.5 Ascensia Recent Development

11.7 Becton Dickinson

11.7.1 Becton Dickinson Company Details

11.7.2 Becton Dickinson Business Overview

11.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Introduction

11.7.4 Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.7.5 Becton Dickinson Recent Development

11.8 Debiotech S.A.

11.8.1 Debiotech S.A. Company Details

11.8.2 Debiotech S.A. Business Overview

11.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Introduction

11.8.4 Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.8.5 Debiotech S.A. Recent Development

11.9 Eli Lilly And Co.

11.9.1 Eli Lilly And Co. Company Details

11.9.2 Eli Lilly And Co. Business Overview

11.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Introduction

11.9.4 Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.9.5 Eli Lilly And Co. Recent Development

11.10 Glaxo Smithkline

11.10.1 Glaxo Smithkline Company Details

11.10.2 Glaxo Smithkline Business Overview

11.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Introduction

11.10.4 Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.10.5 Glaxo Smithkline Recent Development

11.11 Inlight Solutions Inc.

11.11.1 Inlight Solutions Inc. Company Details

11.11.2 Inlight Solutions Inc. Business Overview

11.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Introduction

11.11.4 Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.11.5 Inlight Solutions Inc. Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Details

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Introduction

11.12.4 Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.12.5 Johnson & Johnson Recent Development

11.13 Lifescan Inc.

11.13.1 Lifescan Inc. Company Details

11.13.2 Lifescan Inc. Business Overview

11.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Introduction

11.13.4 Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.13.5 Lifescan Inc. Recent Development

11.14 Medtronic

11.14.1 Medtronic Company Details

11.14.2 Medtronic Business Overview

11.14.3 Medtronic Diabetes Therapeutics and Diagnostics Introduction

11.14.4 Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.14.5 Medtronic Recent Development

11.15 Merck & Co.

11.15.1 Merck & Co. Company Details

11.15.2 Merck & Co. Business Overview

11.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Introduction

11.15.4 Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.15.5 Merck & Co. Recent Development

11.16 Merck KGAA

11.16.1 Merck KGAA Company Details

11.16.2 Merck KGAA Business Overview

11.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Introduction

11.16.4 Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.16.5 Merck KGAA Recent Development

11.17 Nipro Corp.

11.17.1 Nipro Corp. Company Details

11.17.2 Nipro Corp. Business Overview

11.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Introduction

11.17.4 Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.17.5 Nipro Corp. Recent Development

11.18 Novartis Pharma Ag

11.18.1 Novartis Pharma Ag Company Details

11.18.2 Novartis Pharma Ag Business Overview

11.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Introduction

11.18.4 Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.18.5 Novartis Pharma Ag Recent Development

11.19 Novo Nordisk A/S

11.19.1 Novo Nordisk A/S Company Details

11.19.2 Novo Nordisk A/S Business Overview

11.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Introduction

11.19.4 Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.19.5 Novo Nordisk A/S Recent Development

11.20 Owen Mumford Ltd.

11.20.1 Owen Mumford Ltd. Company Details

11.20.2 Owen Mumford Ltd. Business Overview

11.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Introduction

11.20.4 Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.20.5 Owen Mumford Ltd. Recent Development

11.21 Palco Labs Inc.

11.21.1 Palco Labs Inc. Company Details

11.21.2 Palco Labs Inc. Business Overview

11.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Introduction

11.21.4 Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.21.5 Palco Labs Inc. Recent Development

11.22 Roche

11.22.1 Roche Company Details

11.22.2 Roche Business Overview

11.22.3 Roche Diabetes Therapeutics and Diagnostics Introduction

11.22.4 Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.22.5 Roche Recent Development

11.23 Sanofi

11.23.1 Sanofi Company Details

11.23.2 Sanofi Business Overview

11.23.3 Sanofi Diabetes Therapeutics and Diagnostics Introduction

11.23.4 Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.23.5 Sanofi Recent Development

11.24 Takeda Pharmaceutical Co. Ltd.

11.24.1 Takeda Pharmaceutical Co. Ltd. Company Details

11.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview

11.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Introduction

11.24.4 Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.24.5 Takeda Pharmaceutical Co. Ltd. Recent Development

11.25 Terumo Corp.

11.25.1 Terumo Corp. Company Details

11.25.2 Terumo Corp. Business Overview

11.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Introduction

11.25.4 Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2021–2026)

11.25.5 Terumo Corp. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Insulin

Table 3. Key Players of Insulin Delivery

Table 4. Key Players of Oral Hypoglycemic Drugs

Table 5. Key Players of Diagnosis And Monitoring

Table 6. Key Players of Others

Table 7. Global Diabetes Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 10. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2021–2026)

Table 11. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2027–2032)

Table 13. Diabetes Therapeutics and Diagnostics Market Trends

Table 14. Diabetes Therapeutics and Diagnostics Market Drivers

Table 15. Diabetes Therapeutics and Diagnostics Market Challenges

Table 16. Diabetes Therapeutics and Diagnostics Market Restraints

Table 17. Global Diabetes Therapeutics and Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players (2021–2026)

Table 19. Global Top Diabetes Therapeutics and Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Diabetes Therapeutics and Diagnostics Revenue, 2025

Table 20. Ranking of Global Top Diabetes Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Diabetes Therapeutics and Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Diabetes Therapeutics and Diagnostics, Headquarters and Area Served

Table 23. Global Key Players of Diabetes Therapeutics and Diagnostics, Products and Applications

Table 24. Global Key Players of Diabetes Therapeutics and Diagnostics, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Diabetes Therapeutics and Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 27. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2021–2026)

Table 28. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2027–2032)

Table 30. Global Diabetes Therapeutics and Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 31. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2021–2026)

Table 32. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2027–2032)

Table 34. North America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 36. North America Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 49. 77 Elektronika Kft. Company Details

Table 50. 77 Elektronika Kft. Business Overview

Table 51. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product

Table 52. 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 53. 77 Elektronika Kft. Recent Development

Table 54. A. Menarini Diagnostics S.R.L Company Details

Table 55. A. Menarini Diagnostics S.R.L Business Overview

Table 56. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product

Table 57. A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 58. A. Menarini Diagnostics S.R.L Recent Development

Table 59. Abbott Laboratories Company Details

Table 60. Abbott Laboratories Business Overview

Table 61. Abbott Laboratories Diabetes Therapeutics and Diagnostics Product

Table 62. Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 63. Abbott Laboratories Recent Development

Table 64. Agamatrix Inc. Company Details

Table 65. Agamatrix Inc. Business Overview

Table 66. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product

Table 67. Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 68. Agamatrix Inc. Recent Development

Table 69. Animas Corp. Company Details

Table 70. Animas Corp. Business Overview

Table 71. Animas Corp. Diabetes Therapeutics and Diagnostics Product

Table 72. Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 73. Animas Corp. Recent Development

Table 74. Ascensia Company Details

Table 75. Ascensia Business Overview

Table 76. Ascensia Diabetes Therapeutics and Diagnostics Product

Table 77. Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 78. Ascensia Recent Development

Table 79. Becton Dickinson Company Details

Table 80. Becton Dickinson Business Overview

Table 81. Becton Dickinson Diabetes Therapeutics and Diagnostics Product

Table 82. Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 83. Becton Dickinson Recent Development

Table 84. Debiotech S.A. Company Details

Table 85. Debiotech S.A. Business Overview

Table 86. Debiotech S.A. Diabetes Therapeutics and Diagnostics Product

Table 87. Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 88. Debiotech S.A. Recent Development

Table 89. Eli Lilly And Co. Company Details

Table 90. Eli Lilly And Co. Business Overview

Table 91. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product

Table 92. Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 93. Eli Lilly And Co. Recent Development

Table 94. Glaxo Smithkline Company Details

Table 95. Glaxo Smithkline Business Overview

Table 96. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product

Table 97. Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 98. Glaxo Smithkline Recent Development

Table 99. Inlight Solutions Inc. Company Details

Table 100. Inlight Solutions Inc. Business Overview

Table 101. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product

Table 102. Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 103. Inlight Solutions Inc. Recent Development

Table 104. Johnson & Johnson Company Details

Table 105. Johnson & Johnson Business Overview

Table 106. Johnson & Johnson Diabetes Therapeutics and Diagnostics Product

Table 107. Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 108. Johnson & Johnson Recent Development

Table 109. Lifescan Inc. Company Details

Table 110. Lifescan Inc. Business Overview

Table 111. Lifescan Inc. Diabetes Therapeutics and Diagnostics Product

Table 112. Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 113. Lifescan Inc. Recent Development

Table 114. Medtronic Company Details

Table 115. Medtronic Business Overview

Table 116. Medtronic Diabetes Therapeutics and Diagnostics Product

Table 117. Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 118. Medtronic Recent Development

Table 119. Merck & Co. Company Details

Table 120. Merck & Co. Business Overview

Table 121. Merck & Co. Diabetes Therapeutics and Diagnostics Product

Table 122. Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 123. Merck & Co. Recent Development

Table 124. Merck KGAA Company Details

Table 125. Merck KGAA Business Overview

Table 126. Merck KGAA Diabetes Therapeutics and Diagnostics Product

Table 127. Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 128. Merck KGAA Recent Development

Table 129. Nipro Corp. Company Details

Table 130. Nipro Corp. Business Overview

Table 131. Nipro Corp. Diabetes Therapeutics and Diagnostics Product

Table 132. Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 133. Nipro Corp. Recent Development

Table 134. Novartis Pharma Ag Company Details

Table 135. Novartis Pharma Ag Business Overview

Table 136. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product

Table 137. Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 138. Novartis Pharma Ag Recent Development

Table 139. Novo Nordisk A/S Company Details

Table 140. Novo Nordisk A/S Business Overview

Table 141. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product

Table 142. Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 143. Novo Nordisk A/S Recent Development

Table 144. Owen Mumford Ltd. Company Details

Table 145. Owen Mumford Ltd. Business Overview

Table 146. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product

Table 147. Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 148. Owen Mumford Ltd. Recent Development

Table 149. Palco Labs Inc. Company Details

Table 150. Palco Labs Inc. Business Overview

Table 151. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product

Table 152. Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 153. Palco Labs Inc. Recent Development

Table 154. Roche Company Details

Table 155. Roche Business Overview

Table 156. Roche Diabetes Therapeutics and Diagnostics Product

Table 157. Roche Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 158. Roche Recent Development

Table 159. Sanofi Company Details

Table 160. Sanofi Business Overview

Table 161. Sanofi Diabetes Therapeutics and Diagnostics Product

Table 162. Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 163. Sanofi Recent Development

Table 164. Takeda Pharmaceutical Co. Ltd. Company Details

Table 165. Takeda Pharmaceutical Co. Ltd. Business Overview

Table 166. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Product

Table 167. Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 168. Takeda Pharmaceutical Co. Ltd. Recent Development

Table 169. Terumo Corp. Company Details

Table 170. Terumo Corp. Business Overview

Table 171. Terumo Corp. Diabetes Therapeutics and Diagnostics Product

Table 172. Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (US$ Million), 2021–2026

Table 173. Terumo Corp. Recent Development

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

Table 177. Authors List of This Report

List of Figures

Figure 1. Diabetes Therapeutics and Diagnostics Picture

Figure 2. Global Diabetes Therapeutics and Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Diabetes Therapeutics and Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Insulin Features

Figure 5. Insulin Delivery Features

Figure 6. Oral Hypoglycemic Drugs Features

Figure 7. Diagnosis And Monitoring Features

Figure 8. Others Features

Figure 9. Global Diabetes Therapeutics and Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2025 vs 2032

Figure 11. Type 1 Diabetes Case Studies

Figure 12. Type 2 Diabetes Case Studies

Figure 13. Gestational Diabetes Case Studies

Figure 14. Others Case Studies

Figure 15. Diabetes Therapeutics and Diagnostics Report Years Considered

Figure 16. Global Diabetes Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Diabetes Therapeutics and Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Diabetes Therapeutics and Diagnostics Market Share by Region: 2025 vs 2032

Figure 19. Global Diabetes Therapeutics and Diagnostics Market Share by Players in 2025

Figure 20. Global Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2025

Figure 22. North America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Diabetes Therapeutics and Diagnostics Market Share by Country (2021–2032)

Figure 24. United States Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Diabetes Therapeutics and Diagnostics Market Share by Country (2021–2032)

Figure 28. Germany Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Region (2021–2032)

Figure 36. China Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Diabetes Therapeutics and Diagnostics Market Share by Country (2021–2032)

Figure 44. Mexico Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Country (2021–2032)

Figure 48. Israel Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Diabetes Therapeutics and Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. 77 Elektronika Kft. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 52. A. Menarini Diagnostics S.R.L Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 53. Abbott Laboratories Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 54. Agamatrix Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 55. Animas Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 56. Ascensia Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 57. Becton Dickinson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 58. Debiotech S.A. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 59. Eli Lilly And Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 60. Glaxo Smithkline Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 61. Inlight Solutions Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 62. Johnson & Johnson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 63. Lifescan Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 64. Medtronic Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 65. Merck & Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 66. Merck KGAA Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 67. Nipro Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 68. Novartis Pharma Ag Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 69. Novo Nordisk A/S Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 70. Owen Mumford Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 71. Palco Labs Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 72. Roche Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 73. Sanofi Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 74. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 75. Terumo Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2021–2026)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Diabetes Therapeutics and Diagnostics in 2032? zhanKai

The global market size of Diabetes Therapeutics and Diagnostics in 2032 was 153410 Million USD.

Which companies rank high in the global Diabetes Therapeutics and Diagnostics market? shouQi

What is the annual compound growth rate of the global Diabetes Therapeutics and Diagnostics market size from 2026 to 2032? shouQi

What was the global market size of Diabetes Therapeutics and Diagnostics in 2026? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 152
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 141
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-02-27
Pages: 108
USD 2900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-04-15
Pages: 127
USD 4900.00
(Single User License)
Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-01-24
Pages: 166
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2024
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-01-16
Pages: 108
USD 2900.00
(Single User License)

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-07-15
Pages: 152
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 141
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-02-27
Pages: 108
USD 2900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-04-15
Pages: 127
USD 4900.00 (Single User License)
Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-01-24
Pages: 166
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2024
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-01-16
Pages: 108
USD 2900.00 (Single User License)